Therapeutic efficacy of an hTERT promoter-driven oncolytic adenovirus that expresses apoptin in gastric carcinoma

Y XuZ LiuH KongCo-expression of interleukin 12 enhances antitumor effects of a novel chimeric promoter-mediated suicide gene therapy in an immunocompetent mouse modelBiochem Biophys Res Commun412763768201110.1016/j.bbrc.2011.08.07721875574

R AlemanyCancer selective adenovirusesMol Aspects Med284258200710.1016/j.mam.2006.12.002

YS HavivDT CurielConditional gene targeting for cancer gene therapyAdv Drug Deliv Rev53135154200110.1016/S0169-409X(01)00225-311731024

X LiY LiuZ WenPotent antitumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivoMol Cancer910201010.1186/1476-4598-9-1020085660

D SarkarZZ SuN VozhillaES ParkP GuptaPB FisherDual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude miceProc Natl Acad Sci USA1021403414039200510.1073/pnas.050683710216172403

DE PostEM SandbergMM KyleTargeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4Cancer Res6768726881200710.1158/0008-5472.CAN-06-324417638898

OA KovalenkoJ KaplunovU HerbigS DetoledoEI AzzamJH SantosExpression of (NES-)hTERT in cancer cells delays cell cycle progression and increases sensitivity to genotoxic stressPLoS One5e10812201010.1371/journal.pone.001081220520826

JM WojciakMA Martinez-YamoutHJ DysonPE WrightStructural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domainsEMBO J28948958200910.1038/emboj.2009.3019214187

N HotiWH ChowdhuryS MustafaArmoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenovirusesCancer Gene Ther17585597201010.1038/cgt.2010.1520448671

AA Danen-Van OorschotDF FischerJM GrimbergenApoptin induces apoptosis in human transformed and malignant cells but not in normal cellsProc Natl Acad Sci USA945843584719979159162

C BackendorfAE VisserAG de BoerApoptin: therapeutic potential of an early sensor of carcinogenic transformationAnnu Rev Pharmacol Toxicol48143169200810.1146/annurev.pharmtox.48.121806.15491017848136

RA SchoopRJ Baatenburg de JongMH NotebornApoptin induces apoptosis in an oral cancer mouse modelCancer Biol Ther713681373200810.4161/cbt.7.9.641918708764

M LosS PanigrahiI RashediApoptin, a tumor-selective killerBiochim Biophys Acta179313351342200910.1016/j.bbamcr.2009.04.00219374922

JL RohnMH NotebornThe viral death effector Apoptin reveals tumor-specific processesApoptosis9315322200410.1023/B:APPT.0000025808.48885.9c15258463

YH ZhangSR LeliveldK KooistraRecombinant Apoptin multimers kill tumor cells but are nontoxic and epitope-shielded in a normal-cell-specific fashionExp Cell Res2893646200310.1016/S0014-4827(03)00188-512941602

X LiN JinZ MiAntitumor effects of a recombinant fowlpox virus expressing Apoptin in vivo and in vitroInt J Cancer11929482957200610.1002/ijc.2221517036330

H LianN JinX LiInduction of an effective antitumor immune response and tumor regression by combined administration of IL-18 and ApoptinCancer Immunol Immunother56181192200710.1007/s00262-006-0178-y16767432

Q LiJ ZhuF SunL LiuX LiuY YueOncostatin M promotes proliferation of ovarian cancer cells through signal transducer and activator of transcription 3Int J Mol Med28101108201121399864

SH Zainal AriffinWH Wan OmarZ Zainal AriffinMF SafianS SenafiR Megat Abdul WahabIntrinsic anticarcinogenic effects of Piper sarmentosum ethanolic extract on a human hepatoma cell lineCancer Cell Int96200919257877

E CandalR AnadonWJ DeGripI Rodriguez-MoldesPatterns of cell proliferation and cell death in the developing retina and optic tectum of the brown troutBrain Res Dev Brain Res154101119200510.1016/j.devbrainres.2004.10.00815617760

F PatrascuA CroitoruI GramaticuM AndreiA TeiutanuM DiculescuLocally advanced or metastatic gastric cancer - new therapeutic solutionsRev Med Chir Soc Med Nat Iasi11520262011(In Romanian)

AN MilneF CarneiroC O’MorainGJ OfferhausNature meets nurture: molecular genetics of gastric cancerHum Genet126615628200910.1007/s00439-009-0722-x19657673

CL WuGS ShiehCC ChangTumor-selective replication of an oncolytic adenovirus carrying oct-3/4 response elements in murine metastatic bladder cancer modelsClin Cancer Res1412281238200810.1158/1078-0432.CCR-07-104718281558

DH KirnF McCormickReplicating viruses as selective cancer therapeuticsMol Med Today2519527199610.1016/S1357-4310(97)81456-69015793

J ShislerP Duerksen-HughesTM HermistonWS WoldLR GoodingInduction of susceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesisJ Virol70687719968523594

U FischerK Schulze-OsthoffNew approaches and therapeutics targeting apoptosis in diseasePharmacol Rev57187215200510.1124/pr.57.2.615914467

C OroDA JansThe tumour specific pro-apoptotic factor apoptin (Vp3) from chicken anaemia virusCurr Drug Targets5179190200410.2174/138945004349063115011951

L GuelenH PatersonJ GakenM MeyersF FarzanehM TavassoliTAT-apoptin is efficiently delivered and induces apoptosis in cancer cellsOncogene2311531165200410.1038/sj.onc.120722414691460

SM ZhuangA ShvartsH van OrmondtAG JochemsenAJ van der EbMH NotebornApoptin, a protein derived from chicken anemia virus, induces p53-independent apoptosis in human osteosarcoma cellsCancer Res5548648919957834613

MH NotebornProteins selectively killing tumor cellsEur J Pharmacol625165173200910.1016/j.ejphar.2009.06.06819836376

V PavetMM PortalJC MoulinR HerbrechtH GronemeyerTowards novel paradigms for cancer therapyOncogene30120201110.1038/onc.2010.46020935674

I ChowdhuryB TharakanGK BhatCaspases - an updateComp Biochem Physiol B Biochem Mol Biol1511027200810.1016/j.cbpb.2008.05.01018602321